Blogg

SWHR Provides Feedback to ICER on Draft Evidence Report on Treatments for Alzheimer’s Disease

SWHR Responds to RFI on Clinical Research Infrastructure and Emergency Clinical Trials

Improving Outcomes for Women with Autoimmune Diseases and Conditions: A Call to Action

It is estimated that between 23.5 million and 50 million Americans are living with autoimmune diseases and conditions, and the […]

SWHR Sends Letter Highlighting Legislative Priorities in Remainder of 117th Congress

SWHR Policy Agenda: Breaking Down the Burden of Alzheimer’s Disease for Women

The Alzheimer’s Association estimates that there are 6.5 million adults age 65 and older who are living with Alzheimer’s disease […]

SWHR Submits Letter to ICER on Draft Evidence Report for Fezolinetant

SWHR Submits Comments to MEDCAC on CMS General Requirements for Clinical Studies Under CED

SWHR’s 2022 Health Care Value Assessment Principles

In 2019, SWHR conceived a set of principles to help ensure value frameworks and assessments reflected factors relevant to women […]

SWHR Provides Public Comments at NCCIH Stakeholder Meeting for Research on Whole-Person Health

SWHR Sends Welcome Letter to NCI Director Bertagnolli